Sacroiliitis in familial Mediterranean fever: A rare joint involvement of the disease
Journal of Paediatrics and Child Health · 2024
DOI: 10.1111/jpc.16623 ↗At a glance
Journal article in Journal of Paediatrics and Child Health, 2024. Written by Emine Özçelik and 11 co-authors. Institution: Division of Pediatric Rheumatology, Department of Pediatrics, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey. Major MEDLINE topics: Familial Mediterranean Fever, Sacroiliitis, Magnetic Resonance Imaging. Cited 7 times so far (Crossref); 22 references.
Abstract (original language)
Aim
Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disease characterised by recurrent episodes of fever and polyserositis. Sacroiliac joint involvement is rare in FMF patients. The purpose of this study was to evaluate the demographic, clinical, laboratory and imaging findings of patients with FMF who developed sacroiliitis.
Methods
The files of paediatric patients aged 0–18 years who were followed up with a diagnosis of FMF were retrospectively reviewed. FMF patients with evidence of sacroiliitis on magnetic resonance imaging (MRI) were included in the study.
Results
Among 1062 FMF patients, 22 (12 males; median age 8.5) (2.1%) of them were found to have sacroiliitis. FMF was diagnosed before sacroiliitis in nine (40.9%) patients and after in 13 (59.1%) patients. The most common symptom in patients with sacroiliitis was low back pain ( n = 21, 95.5%). In MEFV gene analysis, M694V was found in 16 (72.7%) patients and was the most common mutation. MRI showed evidence of sacroiliitis in all patients. All patients were using colchicine. Patients with FMF‐associated sacroiliitis, remission was achieved with non‐steroidal anti‐inflammatory drugs in 12 (54.5%), conventional disease‐modifying antirheumatic drugs in six (27.3%) and tumour necrosis factor inhibitor treatment in four (31.8%). Four (31.8%) patients experienced sacroiliitis when colchicine incompatible and four (31.8%) patients experienced sacroiliitis while using biologic agents for colchicine‐resistant FMF.
Conclusions
FMF‐associated sacroiliitis should be considered especially in patients with M694V mutation if they have symptoms such as low back pain. Colchicine‐resistant FMF patients should be evaluated for sacroiliitis symptoms at each visit.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Pediatric Rheumatology, Department of Pediatrics, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey.
ORCID profiles: Emine Özçelik, Elif Çelikel, Zahide Ekici Tekin, Vildan Güngörer, Cüneyt Karagöl, Melike Mehveş Kaplan, Nimet Öner, Merve Cansu Polat, Didem Öztürk, Mehveş Işıklar Ekici, Yasemin Uğur Es, Banu Çelikel Acar
Cite
APA
Özçelik, E., Çelikel, E., Tekin, Z. E., Güngörer, V., Karagöl, C., Kaplan, M. M., Öner, N., Polat, M. C., Öztürk, D., Ekici, M. I., Es, Y. U., & Acar, B. Ç. (2024). Sacroiliitis in familial Mediterranean fever: A rare joint involvement of the disease. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16623
Vancouver
Özçelik E, Çelikel E, Tekin ZE, Güngörer V, Karagöl C, Kaplan MM, et al. Sacroiliitis in familial Mediterranean fever: A rare joint involvement of the disease. Journal of Paediatrics and Child Health. 2024. doi:10.1111/jpc.16623
BibTeX
@article{zelik2024,
author = {Özçelik, Emine and Çelikel, Elif and Tekin, Zahide Ekici and Güngörer, Vildan and Karagöl, Cüneyt and Kaplan, Melike Mehveş and Öner, Nimet and Polat, Merve Cansu and Öztürk, Didem and Ekici, Mehveş Işıklar and Es, Yasemin Uğur and Acar, Banu Çelikel},
title = {Sacroiliitis in familial Mediterranean fever: A rare joint involvement of the disease},
journal = {Journal of Paediatrics and Child Health},
year = {2024},
doi = {10.1111/jpc.16623}
}
EUVIMED